Self-breaking tablet and capsule formulations with a similar in vitro drug release profile for whole tablet and when broken and/or a bioequivalent drug release profile when taken whole or when broken are provided. Methods for production of these formulations and tablets and their administration are also provided.
申请公布号
US2011280936(A1)
申请公布日期
2011.11.17
申请号
US201113104218
申请日期
2011.05.10
申请人
NUTALAPATI SIVA RAMA KRISHNA;LAD RAKESHKUMAR KHUSHALBHAI;APTAPHARMA, INC.